Fingolimod (FTY720) Inhibits BCR-ABL Signaling Allosterically by Binding to the Myristate Binding Site

被引：0
|
作者：
Manley, Paul W. [1 ]
Cowan-Jacob, Sandra W. [1 ]
Cozens, Robert [1 ]
Fendrich, Gabriele [1 ]
Jahnke, Wolfgang [1 ]
Roesel, Johannes L. [1 ]
Fabbro, Dorian [1 ]
机构：
[1] Novartis Inst Biomed Res, Basel, Switzerland
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1181 / 1181
页数：1
相关论文
共 50 条
  • [1] Fingolimod/FTY720 regulates astrocyte signaling and migration
    Mullershausen, F.
    Osinde, M.
    Bassilana, F.
    Seuwen, K.
    Sivasankaran, R.
    Mir, A. K.
    Dev, K.
    MULTIPLE SCLEROSIS, 2007, 13 : S148 - S148
  • [2] FTY720 (fingolimod) regulates astrocyte signaling and migration
    Mullershausen, Florian
    Osinde, Maribel
    Shin, Youngah
    Bassilana, Frederic
    Seuwen, Klaus
    Sivasankaran, Rajeev
    Dev, Kumlesh K.
    NEUROLOGY, 2007, 68 (12) : A398 - A398
  • [3] FTY720 (fingolimod) regulates astrocyte signaling and migration
    Mullershausen, F.
    Osinde, M.
    Shin, Y.
    Sivasankaran, R.
    Bassilana, F.
    Seuwen, K.
    Mir, A.
    Dev, K. K.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 197 (02) : 162 - 163
  • [4] CRKL binding to BCR-ABL and BCR-ABL transformation
    Kolibaba, KS
    Bhat, A
    Heaney, C
    Oda, T
    Druker, BJ
    LEUKEMIA & LYMPHOMA, 1999, 33 (1-2) : 119 - 126
  • [5] Direct binding of CRKL to BCR-ABL is not required for BCR-ABL transformation
    Heaney, C
    Kolibaba, K
    Bhat, A
    Oda, T
    Ohno, S
    Fanning, S
    Druker, BJ
    BLOOD, 1997, 89 (01) : 297 - 306
  • [6] THE IMMUNOMODULATORY AGENT FTY720 INDUCES APOPTOSIS AND INHIBITS GROWTH OF BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA CELLS AND OVERCOMES IMATINIB RESISTANCE IN VITRO
    Schmidt-Tanguy, A.
    Badura, S.
    Nijmeijer, B. A.
    Wystub, S.
    Romanski, A.
    Ottmann, O. G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 249 - 250
  • [7] Interactions of FTY720 and FTY720-P with ATP-binding cassette transporters
    Wang, Joy
    Sands, Eric
    Black, Cheryl
    Williams, David
    Chuong, Monica
    Atef, Eman
    LeDuc, Barbara
    Gan, Lawrence
    Xiao, Guangqing
    DRUG METABOLISM REVIEWS, 2011, 43 : 203 - 203
  • [8] Fingolimod (FTY720) Stimulates Ca2+/Calcineurin Signaling in Fission Yeast
    Hagihara, Kanako
    Kita, Ayako
    Mizukura, Aya
    Yao, Mariko
    Kitai, Yuki
    Kunoh, Tatsuki
    Masuko, Takashi
    Matzno, Sumio
    Chiba, Kenji
    Sugiura, Reiko
    PLOS ONE, 2013, 8 (12):
  • [9] Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors
    Zhang, Jianming
    Adrian, Francisco J.
    Jahnke, Wolfgang
    Cowan-Jacob, Sandra W.
    Li, Allen G.
    Iacob, Roxana E.
    Sim, Taebo
    Powers, John
    Dierks, Christine
    Sun, Fangxian
    Guo, Gui-Rong
    Ding, Qiang
    Okram, Barun
    Choi, Yongmun
    Wojciechowski, Amy
    Deng, Xianming
    Liu, Guoxun
    Fendrich, Gabriele
    Strauss, Andre
    Vajpai, Navratna
    Grzesiek, Stephan
    Tuntland, Tove
    Liu, Yi
    Bursulaya, Badry
    Azam, Mohammad
    Manley, Paul W.
    Engen, John R.
    Daley, George Q.
    Warmuth, Markus
    Gray, Nathanael S.
    NATURE, 2010, 463 (7280) : 501 - U116
  • [10] Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways
    Alan Baer
    Winston Colon-Moran
    Nirjal Bhattarai
    Scientific Reports, 8
12345